Impact Factor 4.716 | CiteScore 4.71
More on impact ›
Viral immunology expects novel findings about molecular and cellular mechanisms of host antiviral defense.
Taking advantage of the novel Frontiers publishing concept and unique mechanism for communication between authors and referees, the section aims to provide readers, authors and reviewers an open access to articles reporting novel findings or insightful views improving our understanding of the host antiviral immune system, at molecular, cellular and clinical levels.
Focus of the section:
- Host innate and adaptive immune responses to viral infections.
- Signaling pathways of virus sensors and antiviral molecules.
- Molecular interactions between viral products and host antiviral immune system.
- Organ and cell type specific antiviral immune responses.
- Molecular and cellular mechanisms of human viral disease pathogenesis.
Indexed in: PubMed, MEDLINE, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS, EBSCO, OpenAIRE, Zetoc
PMCID: all published articles receive a PMCID
Viral Immunology welcomes submissions of the following article types: Case Report, Classification, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge and Systematic Review.
All manuscripts must be submitted directly to the section Viral Immunology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com